Published on in Vol 5, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26121, first published .
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study

Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study

Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study

Journals

  1. Banerjee R, Shah N, Dicker A. Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clinical Cancer Informatics 2021;(5):668 View
  2. Rocha V, Fatobene G, Niederwieser D. Increasing access to allogeneic hematopoietic cell transplant: an international perspective. Hematology 2021;2021(1):264 View
  3. Riches M. The new world: hematopoietic stem cell transplant during a pandemic. Current Opinion in Hematology 2021;28(6):389 View
  4. Van Opstal J, Zhao A, Kaplan S, Sung A, Schoemans H. eHealth-Generated Patient Data in an Outpatient Setting after Hematopoietic Stem Cell Transplantation: A Scoping Review. Transplantation and Cellular Therapy 2022;28(8):463 View
  5. Cordeiro A, Fatobene G, Mariano L, Rocha V. Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil. Bone Marrow Transplantation 2022;57(11):1735 View
  6. Koo J, Auletta J, Hartley D, Huber J, Jaglowski S, Kapadia M, Kusnier K, Lehmann L, Maakaron J, Myers K, Pai A, Parker L, Phelan R, Sper C, Rotz S, Dandoy C. Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem. Transplantation and Cellular Therapy 2022;28(11):737 View
  7. Mussetti A, Peric Z, Figueroa C. COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US. Current Opinion in Infectious Diseases 2022;35(4):295 View
  8. Gandhi A, Lee C. Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy. Cancers 2023;15(16):4108 View
  9. Gómez-De León A, Jiménez-Antolinez V, Rodríguez-González V, Gutiérrez-Aguirre C, MacWilliams M, Sánchez-Larrayoz A, Martínez-Calderón K, García Zárate V, Mancías-Guerra C, Rodríguez-Zúñiga A, Sánchez-Arteaga A, Colunga-Pedraza P, Colunga-Pedraza J, Cantú Rodríguez O, Tarín-Arzaga L, González-Llano O, Gómez-Almaguer D. Increasing access to transplantation through telemedicine and patient navigation. Cytotherapy 2024 View
  10. Hurtado L, Gonzalez Concepcion M, Flix-Valle A, Ruiz-Romeo M, Gonzalez-Rodriguez S, Peña M, Paviglianiti A, Pera Jambrina M, Sureda A, Ochoa-Arnedo C, Mussetti A. Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study. JMIR Formative Research 2024;8:e55918 View
  11. Prieto del Prado M, Fernández Avilés F. Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact. Frontiers in Immunology 2024;15 View